JPMorgan Chase Financial Co. LLC has filed a preliminary pricing supplement for its latest offering of contingent income auto-callable securities. This filing, dated November 6, 2026, outlines the terms of a new investment product that aims to attract investors seeking exposure to equity markets while managing risk.
The contingent income auto-callable securities are designed to provide investors with potential quarterly payments based on the performance of three major exchange-traded funds (ETFs): the State Street SPDR S&P 500 ETF Trust, the Invesco QQQ Trust, and the iShares Russell 2000 ETF. The securities will automatically redeem if the closing price of each ETF meets specified thresholds, providing an opportunity for returns while also exposing investors to the risk of losing principal.
Background
JPMorgan Chase Financial Co. LLC, a subsidiary of JPMorgan Chase & Co., operates within the national commercial banking sector (SIC: 6021). The company is incorporated in Delaware and is headquartered at 383 Madison Avenue, New York, NY. This filing is part of a series of recent filings made on the same day, indicating a strategic push in the financial markets.
What the Filing Says
The filing outlines that the securities will be fully and unconditionally guaranteed by JPMorgan Chase & Co. It states, "All Payments on the Securities Based on the Worst Performing of the State Street SPDR S&P 500 ETF Trust, the Invesco QQQ Trust, and the iShares Russell 2000 ETF." This highlights the structured nature of the investment and the associated risks.
Impact
This offering may affect a range of stakeholders, including investors looking for innovative investment products, as well as competitors in the national commercial banking sector. The structure of these securities, which combines contingent payments with the risk of principal loss, could prompt other banks to enhance their own product offerings in a competitive market.
What's Next
The filing does not specify what happens next, but it indicates that the pricing date is expected to occur on or about November 6, 2026, with a maturity date set for May 10, 2029. Investors will be closely monitoring the performance of the underlying ETFs as the determination dates approach.
Source: SEC Accession Number 0001213900-26-116958
Read Next
BioVie Inc. raises $4.74 million through securities offering
Morgan Stanley Files Free Writing Prospectus for New Securities
OneSpaWorld Holdings officer sells 150,611 shares in filing
Bank of Montreal issues $2.3 million in senior notes
Morgan Stanley Finance files free writing prospectus for new securities
Morgan Stanley Files Free Writing Prospectus for New Securities










